Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon. Nakamura A, Kotaki T, Nagai Y, Takazawa S, et al. PLoS One 2022;17:e0274829.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nakamura A, Kotaki T, Nagai Y, Takazawa S, et al. Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon. PLoS One 2022;17:e0274829.
PMID: 36264936